IP Library Granted Patent US 8,304,511
Granted Patent B2
US 8,304,511 · App. 13/172,043 · Granted Nov 6, 2012

Maleamic acid polymer derivatives and their bioconjugates

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,304,511
App. No.
13/172,043
Granted
Nov 6, 2012
Kind
B2
Abstract

The present invention is directed a method comprising administering a composition to an individual, wherein the composition comprises a plurality of conjugates, each conjugate in the plurality a protein derivatized with a water-soluble polymer, wherein the polymer is coupled to the protein via succinimide groups covalently attached to either cysteine sulfhydryl groups or lysine amino groups, and substantially all of the succinimide groups present in the composition are present in a ring-opened form.

Claims (18)

1. A method comprising administering a composition to an individual, wherein the composition comprises a plurality of conjugates, each conjugate in the plurality a protein derivatized with a water-soluble polymer, wherein the polymer is coupled to the protein via succinimide groups covalently attached to either cysteine sulfhydryl groups or lysine amino groups, and substantially all of the succinimide groups present in the composition are present in a ring-opened form.

2. The method of claim 1 , wherein 95% or greater of all the succinimide groups present in the composition are present in a ring-opened form.

3. The method of claim 1 , wherein the polymer is coupled to the protein via succinimide groups covalently attached to cysteine sulfhydryl groups.

4. The method of claim 3 , wherein 95% or greater of all the succinimide groups present in the composition are present in a ring-opened form.

5. The method of claim 1 , wherein the polymer is coupled to the protein via succinimide groups covalently attached to lysine amino groups.

6. The method of claim 5 , wherein 95% or greater of all the succinimide groups present in the composition are present in a ring-opened form.

7. The method of claim 1 , wherein the water-soluble polymer is selected from the group consisting of a poly(alkylene oxide), poly(vinyl pyrrolidone), poly(vinyl alcohol), polyoxazoline, poly(acryloylmorpholine), and poly(oxyethylated polyol).

8. The method of claim 7 , wherein the water-soluble polymer is a poly(alkylene oxide).

9. The method of claim 8 , wherein the water-soluble polymer is a poly(ethylene glycol).

10. The method of claim 9 , wherein said poly(ethylene glycol) comprises an end-capping moiety.

11. The method of claim 10 , wherein said end-capping moiety is selected from the group consisting alkoxy, substituted alkoxy, alkenyloxy, substituted alkenyloxy, alkynyloxy, substituted alkynyloxy, aryloxy, and substituted aryloxy.

12. The method of claim 11 , wherein said end-capping moiety is selected from the group consisting of methoxy, ethoxy, and benzyloxy.

13. The method of claim 9 , wherein said poly(ethylene glycol) has a nominal average molecular mass of from about 100 daltons to about 100,000 daltons.

14. The method of claim 13 , wherein said poly(ethylene glycol) has a nominal average molecular mass of from about 1,000 daltons to about 80,000 daltons.

15. The method of claim 14 , wherein said poly(ethylene glycol) has a nominal average molecular mass of from about 2,000 daltons to about 50,000 daltons.

16. The method of claim 9 , wherein said poly(ethylene glycol) has a structure selected from the group consisting of linear, branched, forked, and multi-armed.

17. The method of claim 1 , wherein said water-soluble polymer comprises a linker, L, interposed between said water-soluble polymer and said maleimide group.

18. The method of claim 9 , wherein said poly(ethylene glycol) is directly attached to the nitrogen atom of said maleimide group.

Assignments (4)
RELEASE OF SECURITY INTEREST Recorded Apr 17, 2020
From: TC LENDING, LLC, AS COLLATERAL AGENT
To: NEKTAR THERAPEUTICS
Reel/Frame 053180/0009 →
RELEASE OF SECURITY INTEREST RECORDED AT REEL 28571, FRAME 0141 Recorded Oct 14, 2015
From: WELLS FARGO BANK, NATIONAL ASSOCIATION, AS COLLATERAL AGENT
To: NEKTAR THERAPEUTICS
Reel/Frame 036866/0700 →
GRANT OF SECURITY INTEREST IN UNITED STATES PATENTS Recorded Oct 6, 2015
From: NEKTAR THERAPEUTICS
To: TC LENDING, LLC, AS COLLATERAL AGENT
Reel/Frame 036796/0562 →
GRANT OF SECURITY INTEREST Recorded Jul 17, 2012
From: NEKTAR THERAPEUTICS
To: WELLS FARGO BANK, NATIONAL ASSOCIATION, AS COLLATERAL AGENT
Reel/Frame 028571/0141 →